Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5865222 | Complementary Therapies in Medicine | 2016 | 33 Pages |
Abstract
The current evidence demonstrates that oral CHM in combination with NB-UVB has a superior effectiveness in terms of repigmentation rate of vitiligo when compared to NB-UVB alone. Although the overall quality of included trials was low, oral CHM in combination with NB-UVB may be an alternative option of treatment for vitiligo. As to safety, there were only mild adverse events reported without significant renal or liver function impairment. However, there is limited available evidence of long-term follow-up and poor methodological quality of the available trials. Well-designed RCTs of adequate length and sample size that include life quality as an outcome are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Complementary and Alternative Medicine
Authors
Yu-Jung Chen, Yi-Yang Chen, Ching-Yuan Wu, Ching-Chi Chi,